# Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss

> **NCT04718233** · PHASE2 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 80 (actual)

## Conditions studied

- Recurrent Pregnancy Loss

## Interventions

- **DRUG:** Sildenafil 25Mg Tablet
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT04718233
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-05
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-07-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04718233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04718233, "Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04718233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*